Ongoing Research and Development Of Monoclonal Antibodies Therapeutics Market

Monoclonal Antibody Therapeutics Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market – Overview
Frequent approvals of novel monoclonal antibodies and their launches in developed economies are expected to
significantly drive monoclonal antibody therapeutics market growth over the forecast period. Key players in the
market have gained regulatory approvals and have launched their therapies in the market. For instance, in 2015,
the U.S. FDA approved Darzalex, developed by Johnson & Johnson for multiple myeloma. Similarly, in 2017,
Roche was granted accelerated approval to TECENTRIQ (atezolizumab) from the U.S FDA for the treatment of
people with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for cisplatin
chemotherapy.
Moreover, approvals to several combination therapies are further expected to boost the global monoclonal
antibody therapeutics market growth over the forecast period. For instance, in 2017, the U.S. FDA approved
Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients
suffering from multiple myeloma. Moreover, different monoclonal antibodies with unique mechanism of actions
have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PDL1.
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market Taxonomy:
Global Monoclonal Antibody Therapeutics Market, By Source:
Human
Humanized
Chimeric
Others
Global Monoclonal Antibody Therapeutics Market, By Therapeutic Application:
Oncology
Autoimmune Diseases
Infectious Diseases
Hematological Disorders
Others
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2403
REPORT DESCRIPTION
Monoclonal Antibody Therapeutics Market – Key Players
Pfizer
Novartis International AG
Amgen
Sanofi S.A
Merck & Co
GlaxoSmithKline
F. Hoffmann-La Roche
AbbVie
Eily, Lilly
Bristol-Myers Squibb Company
Get More Inf @
https://www.coherentmarketinsights.com/market-insight/monoclonal-antibody-therapeutics-market-2403
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702

Introduction and supposed success of monoclonal antibodies and other biological products has spurred the interest of manufacturers in these therapies.